Similarities and differences between interstitial lung disease associated with rheumatoid arthritis and systemic sclerosis—A retrospective cohort study

This publication has 15 references indexed in Scilit:

• Systemic sclerosis and interstitial lung disease: From pathogenesis, to screening, diagnosis, and classification
  Revista Colombiana de Reumatología, 2023
• A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease
  Arthritis & Rheumatology, 2022
• Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
  American Journal of Respiratory and Critical Care Medicine, 2022
• Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions
  Cellular and Molecular Life Sciences, 2021
• Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
  Annals of the Rheumatic Diseases, 2021
• Spectrum of Fibrotic Lung Diseases
  New England Journal of Medicine, 2020
• Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment
  Current Treatment Options in Rheumatology, 2020
• Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and management
  Clinical Rheumatology, 2020
• Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
  New England Journal of Medicine, 2019
• An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
  American Journal of Respiratory and Critical Care Medicine, 2013